Free Trial

TRACON Pharmaceuticals (TCON) Short Interest Ratio & Short Volume

$0.63
-0.03 (-4.55%)
(As of 07/26/2024 ET)

TRACON Pharmaceuticals Short Interest Data

Current Short Interest
166,100 shares
Previous Short Interest
119,000 shares
Change Vs. Previous Month
+39.58%
Dollar Volume Sold Short
$209,286.00
Short Interest Ratio
0.8 Days to Cover
Last Record Date
June 15, 2024
Outstanding Shares
3,410,000 shares
Float Size
2,500,000 shares
Short Percent of Float
6.64%
Today's Trading Volume
1,578 shares
Average Trading Volume
171,887 shares
Today's Volume Vs. Average
1%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TRACON Pharmaceuticals ?

Sign up to receive the latest short interest report for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TCON Short Interest Over Time

TCON Days to Cover Over Time

TCON Percentage of Float Shorted Over Time

TRACON Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2024166,100 shares $209,286.00 +39.6%6.6%0.8 $1.26
5/31/2024119,000 shares $152,320.00 -4.1%4.8%0.5 $1.28
5/15/2024124,100 shares $201,042.00 -18.9%5.0%0.5 $1.62
4/30/2024153,000 shares $264,690.00 +527.1%7.3%0.6 $1.73
4/15/202424,400 shares $43,920.00 -96.7%1.2%0.1 $1.80
3/31/2024744,900 shares $6.40 million -60.8%N/A0.2 $8.60
3/15/20241,900,000 shares $712,500.00 +323.5%N/A0.7 $0.38
2/29/2024448,700 shares $81,214.70 -47.6%N/A0.2 $0.18
2/15/2024856,300 shares $162,868.26 -29.8%N/A0.5 $0.19
1/31/20241,220,000 shares $235,948.00 +43.0%N/A0.2 $0.19
1/15/2024853,100 shares $144,344.52 -52.3%N/A0.2 $0.17
12/31/20231,790,000 shares $313,429.00 +178.9%N/A0.4 $0.18
12/15/2023641,900 shares $120,035.30 -74.2%N/A0.1 $0.19
11/30/20232,490,000 shares $509,205.00 +23.9%N/A0.6 $0.20
11/15/20232,010,000 shares $340,092.00 +53.4%N/A0.5 $0.17
10/31/20231,310,000 shares $227,547.00 +265.8%N/A1.6 $0.17
10/15/2023358,100 shares $68,755.20 +0.8%N/A0.4 $0.19
9/30/2023355,200 shares $63,225.60 -27.5%N/A0.6 $0.18
9/15/2023489,600 shares $124,358.40 +21.0%N/A0.9 $0.25
8/31/2023404,700 shares $106,840.80 +70.1%N/A0.9 $0.26
8/15/2023237,900 shares $63,995.10 -31.8%N/A0.5 $0.27
7/31/2023348,700 shares $104,923.83 +37.9%N/A1 $0.30
7/15/2023252,800 shares $75,713.60 +78.5%N/A0.8 $0.30
6/30/2023141,600 shares $41,205.60 -37.2%N/A0.5 $0.29
6/15/2023225,300 shares $114,474.93 +38.0%N/A1 $0.51
5/31/2023163,300 shares $94,224.10 +1.4%N/A0.9 $0.58
5/15/2023161,000 shares $104,682.20 -38.7%N/A0.9 $0.65
4/30/2023262,500 shares $207,112.50 +100.7%N/A1.5 $0.79
4/15/2023130,800 shares $253,752.00 +5.7%N/A0.9 $1.94
3/31/2023123,700 shares $233,793.00 +4.1%N/A1.5 $1.89
3/15/2023118,800 shares $180,576.00 -16.7%N/A1.4 $1.52
2/28/2023142,600 shares $219,604.00 -11.1%N/A0.9 $1.54
2/15/2023160,400 shares $267,868.00 -24.6%N/A1.1 $1.67
1/31/2023212,700 shares $357,336.00 -24.6%N/A1.3 $1.68
1/15/2023282,000 shares $502,834.20 -21.3%N/A1.8 $1.78
12/30/2022358,200 shares $533,718.00 +48.8%N/A2.3 $1.49
12/15/2022240,800 shares $308,224.00 +66.9%N/A1.6 $1.28
11/30/2022144,300 shares $217,171.50 -2.8%N/A2 $1.51
11/15/2022148,500 shares $227,205.00 -1.5%N/A2.1 $1.53
10/31/2022150,700 shares $238,106.00 +23.6%N/A2.1 $1.58
“Generational Bull Run” Incoming (Ad)

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.
10/15/2022121,900 shares $201,135.00 -5.9%N/A1.9 $1.65
9/30/2022129,500 shares $216,265.00 -7.2%N/A2.1 $1.67
9/15/2022139,600 shares $262,448.00 +6.8%N/A2.2 $1.88
8/31/2022130,700 shares $258,786.00 -0.5%N/A2 $1.98
8/15/2022131,300 shares $278,356.00 +5.0%N/A1.9 $2.12
7/31/2022125,100 shares $221,427.00 -9.7%N/A1.8 $1.77
7/15/2022138,600 shares $248,094.00 -15.4%N/A1.7 $1.79
6/30/2022163,800 shares $327,600.00 +26.7%N/A1.8 $2.00
6/15/2022129,300 shares $173,262.00 +0.4%N/A1.4 $1.34
5/31/2022128,800 shares $221,536.00 -6.0%N/A1.3 $1.72
5/15/2022137,000 shares $228,790.00 -15.5%N/A1.3 $1.67
4/30/2022162,200 shares $326,022.00 +9.5%N/A1.6 $2.01
4/15/2022148,200 shares $371,982.00 -18.4%N/A1.4 $2.51
3/31/2022181,600 shares $477,608.00 -35.6%N/A1.7 $2.63
3/15/2022281,800 shares $760,860.00 -1.8%N/A1.3 $2.70
2/28/2022287,000 shares $726,110.00 -7.0%N/A1.2 $2.53
2/15/2022308,600 shares $802,360.00 -0.4%N/A1.2 $2.60
1/31/2022309,700 shares $802,123.00 -3.7%N/A1.1 $2.59
1/15/2022321,500 shares $758,740.00 +4.7%N/A1.1 $2.36
12/31/2021307,200 shares $850,944.00 +38.0%N/A1.1 $2.77
12/15/2021222,600 shares $560,952.00 -0.3%N/A0.9 $2.52
11/30/2021223,300 shares $580,580.00 -9.6%N/A1.2 $2.60
11/15/2021246,900 shares $802,425.00 -2.1%N/A1.6 $3.25
10/29/2021252,300 shares $933,510.00 -7.2%N/A1.7 $3.70
10/15/2021271,800 shares $1.03 million -12.2%N/A1.4 $3.78
9/30/2021309,700 shares $1.20 million +2.4%N/A1.1 $3.87
9/15/2021302,500 shares $1.15 million -39.8%N/A1.1 $3.79
8/31/2021502,100 shares $1.88 million -8.0%N/A1.7 $3.74
8/13/2021545,700 shares $1.95 million -11.5%N/A1.9 $3.57
7/30/2021616,800 shares $2.31 million -11.2%N/A2.3 $3.75
7/15/2021694,400 shares $3.60 million -1.0%N/A3.1 $5.18
6/30/2021701,500 shares $4.55 million +14.1%5.2%4.8 $6.49
6/15/2021614,800 shares $3.89 million +21.3%4.6%3.8 $6.32
5/28/2021506,800 shares $3.06 million -4.5%3.8%2.9 $6.03
5/14/2021530,500 shares $3.08 million -2.6%3.6%2.2 $5.81
4/30/2021544,600 shares $4.01 million -6.2%3.7%1.8 $7.36
4/15/2021580,800 shares $4.76 million +17.1%3.9%1.5 $8.19
3/31/2021496,000 shares $3.85 million +3.0%3.4%1.1 $7.77
3/15/2021481,400 shares $4.46 million +37.4%3.3%0.8 $9.27
2/26/2021350,500 shares $3.15 million -37.5%2.4%0.6 $9.00
2/12/2021560,500 shares $6.17 million +56.7%4.3%0.9 $11.00
1/29/2021357,800 shares $3.26 million +7.5%2.8%0.4 $9.10
1/15/2021332,800 shares $3.71 million -39.3%2.6%0.4 $11.16
12/31/2020548,000 shares $5.83 million +205.6%4.2%0.7 $10.64
12/15/2020179,300 shares $1.46 million +34.0%1.4%0.2 $8.14
11/30/2020133,800 shares $1.18 million -41.3%1.0%0.1 $8.83
11/15/2020228,100 shares $1.74 million +6.1%1.8%0.2 $7.63
10/30/2020215,000 shares $1.08 million -7.5%1.7%0.1 $5.01
10/15/2020232,300 shares $1.26 million -32.4%1.9%0.1 $5.42
9/30/2020343,500 shares $1.78 million -35.4%4.3%0.2 $5.17
“Generational Bull Run” Incoming (Ad)

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.
9/15/2020531,900 shares $2.41 million +115.2%6.6%0.3 $4.53
8/31/2020247,200 shares $467,208.00 +779.7%3.1%0.2 $1.89
8/14/202028,100 shares $48,051.00 -54.6%0.4%0 $1.71
7/31/202061,900 shares $102,135.00 -49.1%0.8%0.1 $1.65
7/15/2020121,500 shares $230,850.00 +66.4%2.5%0.3 $1.90
6/30/202073,000 shares $147,460.00 +322.0%1.5%0.2 $2.02
6/15/202017,300 shares $34,600.00 -23.1%0.4%0.1 $2.00
5/29/202022,500 shares $51,750.00 -46.9%0.5%0.1 $2.30
5/15/202042,400 shares $84,800.00 +66.9%0.9%0.2 $2.00
4/30/202025,400 shares $51,054.00 -56.4%0.5%0.1 $2.01
4/15/202058,200 shares $142,590.00 -27.2%1.3%0.2 $2.45
3/31/202079,900 shares $144,619.00 -14.9%1.7%0.2 $1.81
3/13/202093,900 shares $170,898.00 +16.2%2.8%0.3 $1.82
2/28/202080,800 shares $93,728.00 -40.0%2.4%0.1 $1.16
2/14/2020134,600 shares $239,588.00 +4.1%4.0%0.2 $1.78
1/31/2020129,300 shares $393,072.00 +81.4%4.0%0.2 $3.04
1/15/202071,300 shares $298,747.00 +30.1%2.1%0.2 $4.19
12/31/201954,800 shares $229,612.00 +218.6%1.9%0.2 $4.19

TCON Short Interest - Frequently Asked Questions

What is TRACON Pharmaceuticals' current short interest?

Short interest is the volume of TRACON Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 166,100 shares of TCON short. 6.64% of TRACON Pharmaceuticals' shares are currently sold short. Learn More on TRACON Pharmaceuticals' current short interest.

What is a good short interest ratio for TRACON Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCON shares currently have a short interest ratio of 1.0. Learn More on TRACON Pharmaceuticals's short interest ratio.

What is a good short interest percentage for TRACON Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.64% of TRACON Pharmaceuticals' floating shares are currently sold short.

Is TRACON Pharmaceuticals' short interest increasing or decreasing?

TRACON Pharmaceuticals saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 166,100 shares, an increase of 39.6% from the previous total of 119,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TRACON Pharmaceuticals' float size?

TRACON Pharmaceuticals currently has issued a total of 3,410,000 shares. Some of TRACON Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRACON Pharmaceuticals currently has a public float of 2,500,000 shares.

How does TRACON Pharmaceuticals' short interest compare to its competitors?

6.64% of TRACON Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to TRACON Pharmaceuticals: TC Biopharm (Holdings) Plc (0.39%), Titan Pharmaceuticals, Inc. (1.36%), BioCardia, Inc. (2.28%), Creative Medical Technology Holdings, Inc. (1.16%), Avalon GloboCare Corp. (1.72%), Palisade Bio, Inc. (5.97%), Genetic Technologies Limited (0.44%), Finch Therapeutics Group, Inc. (2.83%), Windtree Therapeutics, Inc. (10.66%), Scinai Immunotherapeutics Ltd. (9.65%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short TRACON Pharmaceuticals stock?

Short selling TCON is an investing strategy that aims to generate trading profit from TRACON Pharmaceuticals as its price is falling. TCON shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TRACON Pharmaceuticals?

A short squeeze for TRACON Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCON, which in turn drives the price of the stock up even further.

How often is TRACON Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCON, twice per month. The most recent reporting period available is June, 15 2024.



This page (NASDAQ:TCON) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners